Agendia Pays $8.25M In FCA Suit Over Delayed Cancer Tests
The California molecular diagnostics testing company Agendia agreed Wednesday to pay the U.S. Department of Justice $8.25 million to settle a whistleblower's False Claims Act lawsuit alleging that it intentionally delayed...To view the full article, register now.
Already a subscriber? Click here to view full article